The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Pyridin-4-yl-5-trifluoromethyl-1,3-dihydro-imidazo[4,5-b]pyridin-2-one ID: ALA2114202
PubChem CID: 10065195
Max Phase: Preclinical
Molecular Formula: C13H7F5N4O
Molecular Weight: 330.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Oc1nc2cc(-c3ccncc3)c(C(F)(F)C(F)(F)F)[nH]c-2n1
Standard InChI: InChI=1S/C13H7F5N4O/c14-12(15,13(16,17)18)9-7(6-1-3-19-4-2-6)5-8-10(21-9)22-11(23)20-8/h1-5H,(H2,20,21,22,23)
Standard InChI Key: PESFXPODUIUSOI-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
2.7750 -2.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9875 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2667 -2.1750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5542 -1.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 -1.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 -2.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -0.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5542 -0.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 -0.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2667 -0.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0792 -1.3292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1583 -0.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5875 0.3083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8708 0.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5833 -0.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1583 0.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8708 -0.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8770 -3.4125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.5520 -3.4125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 -3.8250 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.9594 -1.9615 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 -1.3500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 1 0
5 1 1 0
6 4 1 0
7 5 2 0
8 10 1 0
9 2 1 0
10 9 2 0
11 5 1 0
12 8 1 0
13 15 2 0
14 16 2 0
15 17 1 0
16 12 1 0
17 12 2 0
9 7 1 0
8 4 2 0
13 14 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
6 22 1 0
6 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 330.22Molecular Weight (Monoisotopic): 330.0540AlogP: 3.33#Rotatable Bonds: 2Polar Surface Area: 74.69Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.29CX Basic pKa: 4.55CX LogP: 3.21CX LogD: 3.20Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.71Np Likeness Score: -0.64
References 1. Singh B, Bacon ER, Robinson S, Fritz RK, Lesher GY, Kumar V, Dority JA, Reuman M, Kuo GH, Eissenstat MA.. (1994) Novel cAMP PDE III inhibitors: imidazo[4,5-b]pyridin-2(3H)-ones and thiazolo[4,5-b]pyridin-2(3H)-ones and their analogs., 37 (2): [PMID:8295212 ] [10.1021/jm00028a007 ]